Investors Asset Management of Georgia’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Investors Asset Management of Georgia’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12	Closed	-$1K	–	532
2022 Q3	$1K	Hold	12	–	–	﹤0.01%	606
2022 Q2	$1K	Buy	+12	New	+$901	﹤0.01%	570

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $3.05B AUM 42.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.44B AUM 23.16% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Investors Asset Management of Georgia's XBI Position: Q4 2022 in Review

Investors Asset Management of Georgia sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2022, closing a stake of 12 shares — an estimated $1K sold.

Investors Asset Management of Georgia first reported a position in XBI in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 746 funds tracked by Wall St. Rank hold XBI as of Q4 2022.

Investors Asset Management of Georgia reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2022 after selling out during the quarter.
Investors Asset Management of Georgia sold 12 State Street SPDR S&P Biotech ETF shares in Q4 2022, an estimated $1K.
Investors Asset Management of Georgia first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 2 quarters.
Investors Asset Management of Georgia's State Street SPDR S&P Biotech ETF position peaked at $1K in Q3 2022.
746 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2022.

Based on Investors Asset Management of Georgia's 13F filing for Q4 2022, filed 2 Feb 2023.